Pulmicort Asthma Prevention (Post-PAC)
|ClinicalTrials.gov Identifier: NCT00233584|
Recruitment Status : Completed
First Posted : October 6, 2005
Last Update Posted : January 14, 2008
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Procedure: Pulmicort (budesonide) pMDI||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||400 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)|
|Study Start Date :||July 2001|
|Actual Primary Completion Date :||May 2006|
|Actual Study Completion Date :||June 2006|
- Success rate of the treatment algorithm: Frequency of protocol deviations, asthma exacerbations, different treatment steps.
- Efficacy - development of lung function.
- Acceptability of the treatment algorithm by the parents.
- Growth rate and BMD.
- Exhaled nitrogen Oxide, bronchohyperresponsiveness.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00233584
|Study Director:||AstraZeneca Denmark Medical Director, MD||AstraZeneca|